XCNQ
TRUE
, Last price
CAD
Name
Treatment.com International Inc
Chart & performance
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Rocket Doctor AI is a pioneering company dedicated to enhancing the healthcare sector. They achieve this by strategically deploying advanced artificial intelligence alongside the highest clinical standards, effectively addressing existing inefficiencies and challenges within the industry. Through the collaborative efforts and global insights of hundreds of medical professionals, Rocket Doctor AI has developed the Global Library of Medicine (GLM). This sophisticated and personalized AI engine is specifically designed for healthcare applications. The GLM is fortified by over 10,000 meticulously reviewed expert medical analyses, offering validated clinical insights and comprehensive support to all healthcare providers. Its functionalities extend to recommending diagnostic procedures—encompassing physical examinations, laboratory tests, and imaging—as well as suggesting appropriate billing classifications. A primary goal of the GLM is to substantially reduce the administrative burdens faced by medical professionals, including physicians, nurses, and pharmacists.
Headquarters & legal address
800 - 885 West Georgia Street
Vancouver, BC V6C 3H1
CA
Vancouver, BC V6C 3H1
CA
Valuation
Title CAD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|
| 2024‑12 | 2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | |
| Income | ||||||||
Revenues | ||||||||
Cost of revenue | ||||||||
Unusual Expense (Income) | ||||||||
NOPBT | ||||||||
NOPBT Margin | ||||||||
Operating Taxes | ||||||||
Tax Rate | ||||||||
NOPAT | ||||||||
Net income | ||||||||
Dividends | ||||||||
Dividend yield | ||||||||
Proceeds from repurchase of equity | ||||||||
BB yield | ||||||||
| Debt | ||||||||
Debt current | ||||||||
Long-term debt | ||||||||
Deferred revenue | ||||||||
Other long-term liabilities | ||||||||
Net debt | ||||||||
| Cash flow | ||||||||
Cash from operating activities | ||||||||
CAPEX | ||||||||
Cash from investing activities | ||||||||
Cash from financing activities | ||||||||
FCF | ||||||||
| Balance | ||||||||
Cash | ||||||||
Long term investments | ||||||||
Excess cash | ||||||||
Stockholders' equity | ||||||||
Invested Capital | ||||||||
ROIC | ||||||||
ROCE | ||||||||
| EV | ||||||||
Common stock shares outstanding | ||||||||
Price | ||||||||
Market cap | ||||||||
EV | ||||||||
EBITDA | ||||||||
EV/EBITDA | ||||||||
Interest | ||||||||
Interest/NOPBT | ||||||||